lobbying_activities: 1697564
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1697564 | d3050abf-4ed3-4967-9358-45d7fd5806da | Q2 | KASOWITZ LLP | 401103221 | SPECTRUM PHARMACEUTICALS | 2015 | second_quarter | MED | Regulation of the medical use of nuclear materials and its effect on patient access | HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),SENATE | 16000 | 0 | 0 | 2015-07-15T17:10:08.557000-04:00 |